Venture Capital

Jurors end deliberations for a second day in the trial of Elizabeth Holmes.

Jurors ended deliberations for a second day on Tuesday in the fraud trial of Elizabeth Holmes, the founder of the blood testing start-up Theranos. Ms. Holmes, who has pleaded not guilty, faces 11 counts of wire fraud and conspiracy to commit wire fraud. Closing arguments in the case concluded last week. On Monday, jurors began […]

Read More

Jury in Elizabeth Holmes’s Fraud Trial Has Begun Deliberations

A jury on Monday began deliberating the merits of the fraud trial against Elizabeth Holmes, the entrepreneur accused of lying to investors and patients about her blood testing start-up, Theranos. Ms. Holmes’s trial has stretched nearly four months, with testimony from dozens of witnesses including scientists, chief executives and a four-star general. The proceedings have […]

Read More

Elizabeth Holmes Trial: Closing Arguments Are Set to Begin

SAN JOSE, Calif. — For Elizabeth Holmes, it all boils down to intent. On Thursday, prosecutors and defense lawyers laid out their closing arguments in the fraud trial of the founder of Theranos, the failed blood testing start-up. In what was effectively their last shot at convincing jurors, each side framed their arguments around the […]

Read More

Elizabeth Holmes Testimony: Updates From Day 4

SAN JOSE, Calif. — Elizabeth Holmes, the founder of the failed blood testing start-up Theranos, took the stand for a fourth day on Monday to defend herself in a fraud trial that has been billed as a test of start-up hubris and hype. Ms. Holmes faces 11 charges of defrauding patients, doctors and investors by […]

Read More

Elizabeth Holmes Hones Her Defense in Day 2 of Testimony

But experts have argued that she had no choice but to defend herself, given the evidence presented by prosecutors. That has included text messages that showed Ms. Holmes was aware of Theranos’s technology problems and testimony about faked demonstrations of its abilities. Prosecutors also revealed that after an employee, Erika Cheung, spoke to regulators about […]

Read More